These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27019557)

  • 1. Comparative Pharmacokinetics of Ginsenoside Rg3 and Ginsenoside Rh2 after Oral Administration of Ginsenoside Rg3 in Normal and Walker 256 Tumor-bearing Rats.
    Fan H; Xiao-Ling S; Yaliu S; Ming-Ming L; Xue F; Xian-Sheng M; Li F
    Pharmacogn Mag; 2016; 12(45):21-4. PubMed ID: 27019557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tissue distribution of ginsenoside Rh2 and Rg3 epimers after oral administration of BST204, a purified ginseng dry extract, in rats.
    Bae SH; Park JB; Zheng YF; Jang MJ; Kim SO; Kim JY; Yoo YH; Yoon KD; Oh E; Bae SK
    Xenobiotica; 2014 Dec; 44(12):1099-107. PubMed ID: 24933530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective determination of ginsenosides Rg3 and Rh2 epimers in rat plasma by LC-MS/MS: application to a pharmacokinetic study.
    Bae SH; Zheng YF; Yoo YH; Kim JY; Kim SO; Jang MJ; Seo JH; Bae SK
    J Sep Sci; 2013 Jun; 36(12):1904-12. PubMed ID: 23559579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High performance liquid chromatographic-mass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studies.
    Xie HT; Wang GJ; Sun JG; Tucker I; Zhao XC; Xie YY; Li H; Jiang XL; Wang R; Xu MJ; Wang W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):167-73. PubMed ID: 15734156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rh2 reduces ischemic brain injury in rats.
    Park EK; Choo MK; Oh JK; Ryu JH; Kim DH
    Biol Pharm Bull; 2004 Mar; 27(3):433-6. PubMed ID: 14993818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities.
    Bae EA; Han MJ; Choo MK; Park SY; Kim DH
    Biol Pharm Bull; 2002 Jan; 25(1):58-63. PubMed ID: 11824558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants.
    Bae EA; Han MJ; Kim EJ; Kim DH
    Arch Pharm Res; 2004 Jan; 27(1):61-7. PubMed ID: 14969341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatoprotective effect of 20(S)-ginsenosides Rg3 and its metabolite 20(S)-ginsenoside Rh2 on tert-butyl hydroperoxide-induced liver injury.
    Lee HU; Bae EA; Han MJ; Kim DH
    Biol Pharm Bull; 2005 Oct; 28(10):1992-4. PubMed ID: 16204963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective pharmacokinetic and metabolism studies of 20(S)- and 20(R)-ginsenoside Rg₃ epimers in rat plasma by liquid chromatography-electrospray ionization mass spectrometry.
    Peng M; Li X; Zhang T; Ding Y; Yi Y; Le J; Yang Y; Chen X
    J Pharm Biomed Anal; 2016 Mar; 121():215-224. PubMed ID: 26826673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of ginsenosides Rg3 and Rh2 from North American ginseng.
    Popovich DG; Kitts DD
    Phytochemistry; 2004 Feb; 65(3):337-44. PubMed ID: 14751305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells.
    Bae EA; Kim EJ; Park JS; Kim HS; Ryu JH; Kim DH
    Planta Med; 2006 Jun; 72(7):627-33. PubMed ID: 16673329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of bioactive ginsenosides Rh2 and Rg3 by metabolically engineered yeasts.
    Wang P; Wei Y; Fan Y; Liu Q; Wei W; Yang C; Zhang L; Zhao G; Yue J; Yan X; Zhou Z
    Metab Eng; 2015 May; 29():97-105. PubMed ID: 25769286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the expression level of recombinant ginsenoside-transforming β-glucosidase in GRAS hosts and mass production of the ginsenoside Rh2-Mix.
    Siddiqi MZ; Cui CH; Park SK; Han NS; Kim SC; Im WT
    PLoS One; 2017; 12(4):e0176098. PubMed ID: 28423055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic Comparison of 20(R)- and 20(S)-Ginsenoside Rh1 and 20(R)- and 20(S)-Ginsenoside Rg3 in Rat Plasma following Oral Administration of Radix Ginseng Rubra and Sheng-Mai-San Extracts.
    Fan X; Xu Y; Zhu D; Ji Y
    Evid Based Complement Alternat Med; 2017; 2017():6451963. PubMed ID: 28620420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of broad-spectrum antibiotics on the metabolism and pharmacokinetics of ginsenoside Rb1: a study on rats׳ gut microflora influenced by lincomycin.
    Xu R; Peng Y; Wang M; Fan L; Li X
    J Ethnopharmacol; 2014 Dec; 158 Pt A():338-44. PubMed ID: 25446586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of Rare Ginsenosides Rg3 and Rh2 by Endophytic Bacteria from
    Yan H; Jin H; Fu Y; Yin Z; Yin C
    J Agric Food Chem; 2019 Aug; 67(31):8493-8499. PubMed ID: 31310523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 20(S)-ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons.
    Lee E; Kim S; Chung KC; Choo MK; Kim DH; Nam G; Rhim H
    Eur J Pharmacol; 2006 Apr; 536(1-2):69-77. PubMed ID: 16563373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic study of ginsenoside Rg3 and glimepiride in type 2 diabetic rats by liquid chromatography coupled with quadrupole-Orbitrap mass spectrometry.
    Yang D; Li X; Fu Y; Tao X; Zheng F; Yu J; Yue H; Dai Y
    Rapid Commun Mass Spectrom; 2021 Jun; 35(11):e9083. PubMed ID: 33742471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous quantification of twenty-one ginsenosides and their three aglycones in rat plasma by a developed UFLC-MS/MS assay: Application to a pharmacokinetic study of red ginseng.
    Zhou QL; Zhu DN; Yang YF; Xu W; Yang XW
    J Pharm Biomed Anal; 2017 Apr; 137():1-12. PubMed ID: 28086165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced oral bioavailability and anti-tumour effect of paclitaxel by 20(s)-ginsenoside Rg3 in vivo.
    Yang LQ; Wang B; Gan H; Fu ST; Zhu XX; Wu ZN; Zhan DW; Gu RL; Dou GF; Meng ZY
    Biopharm Drug Dispos; 2012 Nov; 33(8):425-36. PubMed ID: 22898996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.